High-risk interim PET negative patients in Hodgkin's lymphoma

被引：2
|
作者：
Meignan, Michel [1 ]
机构：
[1] Univ Paris Est Creteil, Hop Henri Mondor, LYSA Imaging, Dept Nucl Med, F-94010 Creteil, France
来源：
LANCET HAEMATOLOGY | 2016年 / 3卷 / 10期
关键词：
METABOLIC TUMOR VOLUME;
D O I：
10.1016/S2352-3026(16)30126-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E449 / E450
页数：2
相关论文
共 50 条
  • [31] TREATMENT HETEROGENEITY OF HIGH-RISK CLASSICAL HODGKIN LYMPHOMA IN PEDIATRIC AND AYA PATIENTS
    Kamat, Aarti
    Goldman, Joshua
    King, Madeleine
    Walling, Emily
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S60 - S60
  • [32] Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma
    Al-Ibraheem, Akram
    Anwer, Farah
    Juweid, Malik E.
    Shagera, Qaid Ahmed
    Khalaf, Aysar N.
    Obeidat, Shahed
    Mansour, Areen
    Ma'koseh, Mohammad
    Halahleh, Khalid
    Jaradat, Imad
    Almasri, Nidal
    Mansour, Asem
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [33] Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma
    Strigari, Lidia
    Attili, Andrea
    Duggento, Andrea
    Chiaravalloti, Agostino
    Schillaci, Orazio
    Guerrisi, Maria Giovanna
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (01) : 16 - 22
  • [34] Is Interim Pet-CT Scan Influencing the Choice of Subsequent Therapy in Hodgkin's Lymphoma Patients in Lebanon?
    Kerbage, Fouad
    Massoud, Marcel
    Akoury, Elie
    Rached, Layale
    Sakr, Riwa
    Rameh, Georges
    Nasr, Fady
    Chahine, Georges
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S320 - S320
  • [35] Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma
    Avigdor, A.
    Bulvik, S.
    Levi, I.
    Dann, E. J.
    Shemtov, N.
    Perez-Avraham, G.
    Shimoni, A.
    Nagler, A.
    Ben-Bassat, I.
    Polliack, A.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 126 - 132
  • [36] Variability of hepatic 18-FDG uptake at interim PET in Hodgkin lymphoma patients
    Gordien, Pierre
    Guyot, Martine
    Bordenave, Laurence
    Hindie, Elif
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [37] Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
    Akram Al-Ibraheem
    Farah Anwer
    Malik E. Juweid
    Qaid Ahmed Shagera
    Aysar N. Khalaf
    Shahed Obeidat
    Areen Mansour
    Mohammad Ma’koseh
    Khalid Halahleh
    Imad Jaradat
    Nidal Almasri
    Asem Mansour
    Scientific Reports, 12
  • [38] Reply: Interim PET Assessment of Advanced Hodgkin Lymphoma: Is It Sufficient?
    Stephens, Deborah M.
    Schoder, Heiko
    Li, Hongli
    Friedberg, Jonathan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (11) : 1695 - 1695
  • [39] Dose-intense cyclophosamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma
    Talbot, J
    Ibom, VK
    Rizzieri, DA
    Barrier, R
    Niedzwieki, D
    DeCastro, CM
    Moore, JO
    Buckley, P
    Laney, R
    Stevenson, D
    Brumbaugh, H
    Gockerman, JP
    CLINICAL LYMPHOMA, 2004, 5 (02): : 116 - 122
  • [40] Interim (18)F-FDG PET prognostic value in Hodgkin lymphoma patients
    Kirienko, Margarita
    Guerra, Luca
    Bolis, Silvia
    Sassone, Marianna
    De Ponti, Elena
    Messa, Cristina
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
12345